The World Health Organization has announced the beginning of a major Ebola vaccine clinical trial in the Democratic Republic of Congo. The study aims to evaluate whether existing and next-generation vaccines can provide protection against the Bundibugyo strain responsible for the current outbreak.
The initiative marks an important step in the global fight against one of the world’s most dangerous infectious diseases. Researchers will monitor vaccine effectiveness among high-risk contacts, while additional vaccine candidates developed using modern biotechnology platforms are expected to join the trial soon.
About the Author
